Product NDC: | 55390-122 |
Proprietary Name: | Cyclosporine |
Non Proprietary Name: | Cyclosporine |
Active Ingredient(s): | 50 mg/mL & nbsp; Cyclosporine |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55390-122 |
Labeler Name: | Bedford Laboratories |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA065004 |
Marketing Category: | ANDA |
Start Marketing Date: | 19991215 |
Package NDC: | 55390-122-10 |
Package Description: | 10 VIAL in 1 BOX (55390-122-10) > 5 mL in 1 VIAL |
NDC Code | 55390-122-10 |
Proprietary Name | Cyclosporine |
Package Description | 10 VIAL in 1 BOX (55390-122-10) > 5 mL in 1 VIAL |
Product NDC | 55390-122 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Cyclosporine |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 19991215 |
Marketing Category Name | ANDA |
Labeler Name | Bedford Laboratories |
Substance Name | CYCLOSPORINE |
Strength Number | 50 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Calcineurin Inhibitor Immunosuppressant [EPC],Calcineurin Inhibitors [MoA] |